Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

Fri, 06/15/18 - 09:51 am
Tags:
Bluebird Bio, sickle cell disease, LentiGlobin
Fri, 06/15/18 - 09:32 am
Tags:
Bluebird Bio, β-thalassemia, sickle cell disease, LentiGlobin
ASCO18: Who were the big winners and losers?
Biopharma Dive
Wed, 06/6/18 - 04:06 pm
Tags:
ASCO 2018, Merck, Loxo Oncology, Bluebird Bio, Celgene, Roche, Nektar
#ASCO18: A Weekend of Surprises
Motley Fool
Sun, 06/3/18 - 09:13 pm
Tags:
ASCO 2018, Bluebird Bio, Loxo Oncology, Nektar Therapeutics, Celgene, Grail
Bluebird Bio's "Impressive" Killer T-Cells Battle Myeloma, But Are Not A Cure Yet
Forbes
Fri, 06/1/18 - 10:48 pm
Tags:
Bluebird Bio, CAR-T, Multiple Myeloma, bb2121, ASCO 2018
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
Tags:
ASCO 2018, European Society of Cardiology, TherapeuticsMD, Abiomed, Incyte, Bluebird Bio, Celgene, Syndax, Loxo Oncology, Exelixis, Karyopharm, Endocyte, Celldex Therapeutics, Jounce Therapeutics, Bristol-Myers Squibb, Nektar
Bluebird widens hunt for TCR therapies in revised Medigene deal
Biopharma Dive
Mon, 05/14/18 - 10:58 pm
Tags:
Bluebird Bio, Medigene, CAR-T
bluebird bio Looks for Data Ahead
Motley Fool
Wed, 05/9/18 - 09:22 pm
Tags:
Bluebird Bio, earnings
2 Beta Thalassemia Drugs Are Fast Approaching the Finish Line
Motley Fool
Sun, 04/22/18 - 11:52 am
Tags:
Celgene, Bluebird Bio, beta thalassemia, LentiGlobin, luspatercept
Is bluebird bio One Step Closer to Its First Commercial Drug?
Motley Fool
Fri, 04/20/18 - 09:58 am
Tags:
Bluebird Bio, beta thalassemia, LentiGlobin
Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
Endpoints
Wed, 04/18/18 - 11:04 pm
Tags:
Bluebird Bio, beta-thalassemia, gene therapy
Celgene, bluebird revise deal to co-develop CAR-T therapy
Biopharma Dive
Thu, 03/29/18 - 11:33 am
Tags:
Celgene, Bluebird Bio, drug development, CAR-T, bb2121, Multiple Myeloma
bluebird bio Updates Plans for the Year Ahead
Motley Fool
Fri, 02/23/18 - 09:29 am
Tags:
Bluebird Bio, earnings
How Celgene Hopes to Cash In on CAR-T
Yahoo/Motley Fool
Sat, 02/17/18 - 10:41 am
Tags:
Celgene, CAR-T, JCAR017, bb2121, Bluebird Bio
As CAR-Ts go from candidates to brands, what's the marketing strategy?
Medical Marketing and Media
Tue, 02/13/18 - 09:01 am
Tags:
CAR-T, drug marketing, JCAR017, Juno Therapeutics, Celgene, bb2121, Bluebird Bio, apalutamide, Janssen
2 Biotech Acquisition Candidates That Could Be Next in M&A Crosshairs
TheStreet.com
Mon, 01/29/18 - 09:29 am
Tags:
biotech, M&A, Bluebird Bio, Amicus Therapeutics
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
Motley Fool
Mon, 01/29/18 - 09:17 am
Tags:
biotech, Bluebird Bio, Madrigal Pharmaceuticals, SAGE Therapeutics
Bluebird Bio Shouldn’t Be Blue About Celgene’s Juno Deal
Washington Post, DC
Tue, 01/23/18 - 08:43 am
Tags:
Bluebird Bio, Celgene, Juno Therapeutics, M&A, CAR-T
5 Biotech Stocks That Could Be Bought Out in 2018
Yahoo/Motley Fool
Sun, 01/14/18 - 09:38 am
Tags:
biotech stocks, Portola Pharmaceuticals, Tesaro, Bluebird Bio, Esperion Therapeutics, GlycoMimetics
JPM18: bluebird set to file 3 drugs for approval by 2019
Biopharma Dive
Wed, 01/10/18 - 10:21 am
Tags:
Bluebird Bio, JPMHC 2018, Lenti-D, gene therapy, LentiGlobin, bb2121

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.